Flaxseed (Linum usitatissimum L.) is an important food, oil, and fiber crop of the family Linaceae. Although flaxseed has been consumed as a food ingredient for several centuries, its nutritional benefits have not yet been completely established. Flaxseed is a good source of lignans, nonstarch polysaccharides, and high-quality proteins. Hence, in this study, we aimed to prepare a bioactive kefir containing flaxseed and to examine the physicochemical characteristics of kefir containing different concentrations of flaxseed. We investigated the pH, and sensory evaluation of bioactive Kefir containing different concentrations of flaxseed. We investigated the pH, total anthocyanins (TAs), and sensory evaluation of bioactive Kefir containing different concentrations of flaxseed. The pH of this bioactive kefir decreased, whereas the TA content increased with increasing incubation time; however, these parameters were not affected by the amount of added flaxseed. As the addition rate of flaxseed increased, the scores for overall acceptability, texture, color, flavor, and taste in sensory evaluations were generally the same as or lower than the control. There were no significant differences in overall acceptability, texture, color, flavor, and taste between the control and treated groups. Therefore, further studies are needed to develop methods for production of health-improving kefir as a dietary supplement based on the functional properties of flaxseed.
such as galacto-oligosaccharides, fructooligo-saccharides and cyclodextrins were recognized as prebiotic substances (Patel and Goyal, 2012) . It could selectively stimulate the growth and activity of the gastrointestinal micro-flora, simultaneously (Lin et al., 2011) Among them, flaxseed (Linum usitatissimum L.) was the seed from the plant and could be consumed as food. Health benefits claims of flax- Rickard et al., (1996) .
Fig. 2. Various beneficent effects of dietary lignan in flaxseed (Linum usitatissimum L.).
Source: Kaur and Gupta (2002) , Westcott and Muir (2003) .
seed were related to its components such as lignans, α-linolenic acid, and soluble dietary fiber or mucilage/gum.
According to various previous researches, the consumption of flaxseed showed several health benefits to prevent colon cancer and to reduce the risk of cardiovascular disease.
In general, flaxseeds were the richest dietary source of lignan precursors (Fig. 1 ). Lignans were polyphenols found in plants and Lignan precursors were found in a wide variety of plantbased foods, including seeds, whole grains, legumes, fruit, and vegetables (Borriello et al., 1985; Rickard et al., 1996) .
When consumed, lignan precursors were converted to the enterolignans, enterodiol and enterolactone, by bacteria that normally colonized the human intestine. Enterodiol and enterolactone had weak estrogenic activity but also could exert biological effects through nonestrogenic mechanisms (Kaur and Gupta, 2002; Westcott and Muir, 2003) . Lignanrich foods were part of a healthful dietary pattern, but further studies on the role of lignans in the prevention of hormone-associated cancers, osteoporosis, and cardiovascular disease would be needed (Fig. 2) .
Besides, the heterogenic polysaccharide known as flaxseed mucilage/gum was the soluble fiber components that constituted approximately 6 to 8% of the whole seed on a dry weight basis. When flaxseed was fermented in vitro, it was resulted in producing the high amounts of acetate and propionate (short-chain fatty acids, SCFA) (Fodje et al., 2009 ). Also, when flaxseed mucilage used as food additives, it could capture free radicals to have anti-tumor and antioxidant properties and could oxidize proteins, lipid or DNA to prevent cancers, simultaneously (Gutiérrez et al., 2010) .
Therefore, the goal of this study was to make the bioactive ducing bioactive kefir (Fig. 4) .Bioactive Kefir samples were added with different concentration rates of flaxseed (Linum usitatissimum L..) (0% as control, 1%, 2%, and 3%). And then the bioactive kefir samples were stored at 4°C.
The pH & titratable acid of the bioactive Kefir added with flaxseed (Linum usitatissimum L.)
The pH of the homogenized yoghurt was determined using a digital pH meter (Orion Star A211, USA) and titratable acid (TA) was determined by titration with 0.1 N NaOH.
Bioactive kefir sample (3 g) was transferred into an Erlenmeyer flask containing 27 mL of dH 2 O. Three to five drops of 0.1% phenolphthalein as pH indicator were added. The yoghurt mixture was then titrated with 0.1N NaOH with continuous stirring until a stable pink color was achieved.
The amount of acid produced during fermentation was calculated as follows:
TTA (% Lactic acid) = Dilution factor × V NaOH × 0.1 N NaOH Factor × 0.009 ×100
Weight of sample (g)
Where V NaOH is the volume (mL) of 0.1 N NaOH required to neutralize the acid; a dilution factor of 10 was used.
The sensory evaluation of the bioactive Kefir added with flaxseed (Linum usitatissimum L.)
The sensory evaluation were carried out by 10 trained panelists between 20 and 50 years of age. The samples were coded with three digit numbers and randomly served at 7 to 10℃ in plastic cups (10 mL). All assessors completed a test assessment form to compare the five sensory attributes (appearance, flavor, taste, and overall acceptability) by using a five-point hedonic scale (1, extremely poor; 2, poor; 3, fair; 4, good; 5, excellent). In general, TA is high depending on the decrease of pH. In this study, the pH was decreased to about 4.51 after the fermentation of kefir premix. The pH value of bioactive kefir added with flaxseed (Linum usitatissimum L.) (1%, 2%, 3%) showed 4.50, 4,52, and 4,51, respectively. Also, the TA was increased to approximately 0.90% after the fermentation of bioactive kefir premix. The TA contents of bioactive kefir added with flaxseed (Linum usitatissimum L.) (1%, 2%, and 3%) showed 0.92%, 0.91%, 0.92%, respectively. Then, the pH and TA value between control keifr and kefir added with flaxseed (Linum usitatissimum L.) (1%, 2%, and 3%)
The statistical analysis
were similar, and there was not any significant difference of TA and pH between control group and treated group.
In general, fermented dairy products were characterized by an acidic taste originating from the presence of lactic acid, a by-product of lactic fermentation. Therefore, titratable acidity (TA) and pH were commonly used as measurements of acidity to determine the quality of milk before and during the production of fermented dairy products (Ntsame Affane et al., 2009) . Furthermore, the acidity of Kefir was very significant during production of kefir, because over or deficient production of acidity in kefir could have an influence to mask the buttery character and then to change the structure of the product (Vedamuthu, 2006) .
When compared to previous researches, the range of pH normally reported for Kefir samples was 3.5~4.5 and the range of TA varied between 0.50 and 1.50 g 100 mL -1 (Simova et al., 2002 : Chen et al., 2012 , and the appropriate range of pH for a commercially available yogurt was between 3.27 and 4.53, and the value of TA was in the range of 0.7% and 1.20% (Adolfsson et al., 2004) .
Namely, the results of this present study showed a very similar trend with those of various previous studies (Simova et al., 2002 : Ntsame Affane et al., 2011 Chen et al., 2012) . Among of many beneficial factors of flaxseed, the flaxseed lignan SECO (secoisolariciresinol) and its diglucoside SDG (SecoisolariciresinolDiglucoside) were recognized as having various benefits for health. Especially, it had the antioxidant properties. In general, after ingestion, SDG was converted to enterolignans (enterodiol and enterolactone) by the intestinal microflora, and hence these metabolites (phytoestrogens) were absorbed and could provide health benefits.
After feeding rats with specific doses of flaxseed, SDG decreased the systolic, diastolic and mean arterial pressure.
SDG reduced the angiotensin I-induced rise in the arterial pressures and hence SDG was a potent Angiotensin-Converting Enzyme (ACE) inhibitor (Paschos et al., 2007; Prasad, 2009 ). And SDG supplementation could protect against the development of chronic diseases, cancer and diabetes on animal studies using various models of rat, mice and rabbit (Adolphe et al., 2010) . Utilization of flaxseed for glycemic control would be associated to the decrease in risk of obesity and dyslipidemia, since these were risk factors for the development of diabetes and resistance to insulin (Bernacchia et al., 2014) .
Flaxseed supplementation resulted in the improvement in anthropometric measurements, blood pressure, and lipid profile in the experimental group, and hence flaxseed had the therapeutic potential in dyslipidemia (Katare et al., 2012) . And Saxena and Katare (2014) also reported that body mass index (BMI) and body weight of the experimental group were significantly reduced as well as systolic and diastolic blood pressure, and a highly significant reduction in total cholesterol, triglycerides, low density lipoproteincholesterol (LDL-C) and low density lipoproteincholesterol (VLDL-C) levels were observed, simultaneously.
Lignans could protect against certain cancers, particularly hormone-sensitive cancers such as those of the breast, endometrium and prostate, by interfering with sex hormone metabolism (Bernacchia et al., 2014) . Flaxseed or pure lignans showed anticarcinogenic effects in many types of cancer, and flaxseed oil could inhibit the growth and development of tumors in the breast of laboratory animals (Lamblin et al., 2008) . The influence of flaxseed lignans and oil components in reducing breast cancer risk and tumor growth was reviewed (Mason and Thompson, 2014) . 
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